Recruiting
Phase 2

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Sponsor:

Triangle Pharmaceuticals

Code:

NCT00017992

Conditions

HIV Infections

Eligibility Criteria

Sex: All

Age: 3 - 17

Healthy Volunteers: Not accepted

Interventions

Lopinavir/Ritonavir

Emtricitabine

Stavudine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-26. This information was provided to ClinicalTrials.gov by Triangle Pharmaceuticals on 2005-06-24.